How a cannabis business sale works

The five stages at a glance, from a seller’s side. Durations are typical ranges from general practice, not guarantees, and stages overlap in a well-run sale.

Stage	What happens	Typical duration
1. Intro call	Goals, license facts, timing, and whether a sale is realistic now	20 minutes, then a few days of follow-up
2. Valuation	Financials recast, reconciled, and priced for your state and license type	1 to 3 months including preparation
3. Confidential marketing	Blind summary, NDA, buyer screening, memorandum, management calls, offers	3 to 9 months
4. LOI to approval	Letter of intent, diligence, purchase agreement, state and local filings	5 to 15 months
5. Close	Funds, inventory count, track-and-trace handover, badges, transition	2 to 6 weeks after approval

Why the total is usually 9 to 18 months is explained in how long it takes to sell a cannabis business.

Intro call

The first step is a free, confidential 20-minute call. Its job is to find out whether a sale is possible, roughly what it could look like, and what would have to be fixed first. No documents are needed and nothing is signed.

Expect questions like these:

1. Which licenses do you hold, in which state and city, and are they adult-use, medical, or both?
2. What are trailing twelve-month revenue and profit, roughly, and are tax filings current?
3. Do you own the real estate, or lease it, and how long is left on the lease?
4. Who owns the company, and do all owners agree on selling?
5. Is anything open with the regulator: an investigation, a fine, a renewal, a holding period?
6. What is driving the timing, and what do you want after the sale: a clean exit, a stay-on role, or a partial sale?

The answers shape everything that follows. License rules decide what can be sold at all. In California a state license cannot be assigned or transferred, so deals are built as ownership changes. New Jersey bars a transfer of more than 50% of ownership until two years after operations begin. A social equity license may be locked for years. A broker should tell you on this call if the honest answer is “not yet”, and what to do in the meantime. If both sides want to go on, the next documents are a mutual NDA and an engagement agreement. How advisors are usually paid is covered in cannabis broker fees and commission.

Buyers start the same way. The call covers target states, license types, budget, proof of funds, and whether the buyer’s owners can pass that state’s background and residency rules.

Valuation

A cannabis valuation is a price range built from verified, current earnings and adjusted for tax, license scarcity, and state conditions. It is not a formula applied to revenue.

The work has four parts:

• Recast the financials. Owner pay, one-time costs, and related-party rent are normalized to show what a new owner would earn.
• Reconcile the numbers. Point-of-sale totals, track-and-trace sales, deposits, and sales and excise tax returns should agree. Buyers discount anything that cannot be tied to the state system, so it is better to find the gaps first.
• Adjust for tax. Section 280E still disallows ordinary deductions for adult-use operators, so two businesses with the same book profit can produce very different after-tax cash. Since the 28 April 2026 order, state-licensed medical activity is in Schedule III and outside 280E going forward, which makes the medical share of sales a valuation input. See how 280E affects valuation.
• Price for the market. A capped-license city supports a different number than an open state with falling wholesale prices. Public comparables set the ceiling: Viridian Capital reported in November 2025 that larger public multi-state operators traded at a median 5.1x enterprise value to 2026 EBITDA, and those buyers rarely pay more for your earnings than the market pays for theirs.

The output is a broker opinion of value: a range, the reasoning, and the likely deal structures at each end of it. It is a pricing tool, not a credentialed appraisal; the difference is set out in appraisal vs broker opinion of value. Methods by license type are on the cannabis business valuation pillar page.

This stage is also where preparation happens: clearing tax balances, fixing the ownership chart so it matches the regulator’s file, getting the landlord’s position on assignment, and assembling the data room. A seller who does this before going to market usually saves more time than it costs.

Confidential marketing

The business is marketed without being named. Buyers learn the identity only after they sign an NDA and pass a basic screen.

The sequence is standard:

1. Blind summary. One or two pages: license type, state or region, revenue band, earnings band, real estate status, reason for sale. No name, no city in a small market, no photos of the storefront.
2. Target list. Operators already licensed in the state, regional groups, multi-state operators with room under ownership caps, and qualified private investors. Direct competitors are approached only with your consent.
3. NDA and screening. Before the memorandum goes out, a buyer signs an NDA and shows who its owners are and where the money comes from. In cannabis, screening has a second purpose. A buyer who cannot pass the regulator’s review cannot close, whatever the offer says. Ownership caps, residency rules, and disqualifying history are checked before anyone negotiates.
4. Confidential information memorandum. The full picture: operations, financials, licenses, compliance history, lease, team, and growth case.
5. Management calls and site visits. Held after hours or off site so staff are not alerted.
6. Offers. Interested buyers submit indications of interest, then a letter of intent.

Confidentiality has limits in a regulated industry. Ownership-change filings go to the state, and some approvals are public. New Jersey’s commission, for example, approves transfers by public resolution naming the licensed business. The aim is to control timing, so that employees and vendors hear it from you. The detail is in selling a cannabis business confidentially.

Offers are compared on more than price. Because SBA SOP 50 10 8 makes marijuana businesses ineligible for 7(a) and 504 loans, most offers mix cash with a seller note, acquirer stock, or an earn-out. The useful comparison is cash at close, the security behind anything deferred, and the buyer’s odds of approval. See cash vs stock vs seller note.

LOI to approval

This is the longest stage. It runs from a signed letter of intent through diligence, the purchase agreement, and the regulator’s review of the new owners.

Letter of intent. The LOI sets price, payment mix, structure, exclusivity period, and key conditions. It is mostly non-binding, but the terms in it are hard to move later. Structure is decided here: an asset sale, or a sale of membership interests or stock. In states where the license cannot move between entities, an equity sale is often the only practical route. The trade-offs are in asset sale vs membership-interest sale.

Diligence. The buyer tests financials against track-and-trace data and tax filings, reviews the compliance file, the lease, contracts, employees, and liens. A prepared data room keeps this to two or three months. The broker’s job is to keep requests moving and to stop small findings turning into price cuts.

Purchase agreement. Attorneys draft it. The cannabis-specific terms are the approval condition, the outside date, deposit and escrow mechanics, tax holdbacks, and what the buyer may and may not do before approval. See regulatory-approval contingencies.

Regulator approval. Each state has its own trigger and process. Massachusetts requires approval before a person or entity acquires 10% or more of equity. Colorado requires proof of local approval, where applicable, and its contingent state approval is valid for one year while the local step is finished. Few regulators publish processing times. One M&A attorney’s April 2026 state-by-state summary reports 90 to 120 days in Michigan for previously vetted buyers, 4 to 8 months in Colorado, 6 to 12 months in California, and 8 to 18 months for some Illinois deals, all measured from a complete application. The rules by state are in change of ownership approval explained.

During the wait you remain the licensee. Keep staffing, inventory, and compliance at normal levels, renew the license on time, and do not hand over control. If the buyer needs a role before approval, it has to fit the state’s rules on interim management services agreements.

Close

Closing happens after approval, usually within two to six weeks. Money moves, ownership changes on the regulator’s records, and the business is handed over.

A cannabis closing has steps an ordinary sale does not:

• Inventory count. Saleable inventory is counted, priced under the agreed method, and reconciled to the track-and-trace system. Aged or untested product is excluded or discounted. See inventory and biomass at closing.
• System handover. Track-and-trace administrator rights, point-of-sale, security and camera systems, and vendor accounts move to the new owner.
• People. Employee badges or agent cards are updated under state rules, and staff are told on a planned date.
• Payoffs and holdbacks. Liens, tax balances, and loans are paid from proceeds. An escrow may be held for tax clearance or indemnity claims.
• Deferred consideration. A seller note, pledge and guaranty documents, stock certificates or book entries, and earn-out terms are signed.
• Banking. The buyer’s accounts go live. A change of ownership usually triggers a fresh compliance review by the bank or credit union.

Most sellers stay for a paid transition period, commonly a few weeks to a few months, to introduce vendors, train the new owner, and answer regulator questions. If you carry a note or an earn-out, your work is not finished at closing: you monitor payments and reporting until the last dollar arrives.

To start at stage one, book a free confidential intro call.

This overview is educational, not legal or tax advice. Timing, approval, price, and financing are never guaranteed, and each state’s rules control.